4//SEC Filing
LENZ BRIAN 4
Accession 0001140361-24-001139
CIK 0001368514other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 9:00 PM ET
Size
6.6 KB
Accession
0001140361-24-001139
Insider Transaction Report
Form 4
LENZ BRIAN
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-12-31$4.52/sh−16,908$76,424→ 749,836 total
Footnotes (3)
- [F1]Includes (i) 135,175 RSUs granted on March 6, 2023 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 103,125 unvested RSUs granted on March 7, 2022 that will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 123,749 unvested Time-Based RSUs granted on September 29, 2021, subject to time based vesting conditions (the "Time-Based RSUs") which shall vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date;
- [F2](continued from footnote 1) (iv) 30,480 unvested RSUs granted on February 25, 2021, of which 27,500 unvested RSUs will vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and 2,980 unvested RSUs are subject to cliff vesting with one-third of such RSUs vesting on each anniversary of the date of grant over three years, subject to the reporting person's continued service as of the applicable vesting date, and in each case will be settled into common stock upon vesting;
- [F3](continued from footnote 2) (v) 10,000 unvested RSUs granted on February 28, 2020, which vest quarterly on each anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting; and (vi) 347,307 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001283260
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 9:00 PM ET
- Size
- 6.6 KB